Targeted Gastrointestinal Antibiotic | Key Therapeutic Uses | Quality and Safety Assurance
Film Coated Tablet | 60 tablets in a box
Rifaximin 550 is a highly effective, non-absorbable oral antibiotic from the rifamycin family, designed for targeted action in the gastrointestinal tract. As a broad-spectrum antimicrobial, Rifaximin 550 is specially formulated to address key gastrointestinal disorders with minimal systemic side effects due to its very low absorption into the bloodstream.
This medication is most widely prescribed for adults to reduce the recurrence of episodes of overt hepatic encephalopathy—a serious complication of advanced liver disease. Additionally, Rifaximin 550 plays a pivotal role in managing irritable bowel syndrome with diarrhea (IBS-D), and traveler’s diarrhea caused by noninvasive strains of E. coli in patients 12 years and older.
Vonage Pharma offers Rifaximin 550 mg tablets under stringent quality standards, ensuring optimal efficacy, safety, and patient tolerability.
Rifaximin 550 exerts its antibacterial action by irreversibly inhibiting bacterial RNA synthesis, leading to bacterial cell death. Its minimal gastrointestinal absorption makes it ideal for treating intestinal infections while avoiding systemic antibiotic side effects.
You can take Rifaximin 550 with or without food. Swallow the tablets whole with water.
Rifaximin 550 boasts a favorable safety profile:
Vonage Pharma manufactures every batch of Rifaximin 550 under strict GMP conditions, therefore ensuring purity and potency for reliable patient outcomes. Moreover, healthcare providers can trust Vonage Pharma for consistent availability, competitive pricing, and expert clinical support.
We understand the complexities and challenges you face in the healthcare industry. That’s why we’re dedicated to providing innovative solutions and insightful knowledge to help you achieve your goals.
Your input is crucial in helping us understand your needs and deliver the most relevant support: